nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP2A6—Prednisolone—ankylosing spondylitis	0.16	0.221	CbGbCtD
Sevoflurane—ALB—Prednisone—ankylosing spondylitis	0.0962	0.133	CbGbCtD
Sevoflurane—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0941	0.13	CbGbCtD
Sevoflurane—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0621	0.086	CbGbCtD
Sevoflurane—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0612	0.0848	CbGbCtD
Sevoflurane—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0497	0.0689	CbGbCtD
Sevoflurane—ALB—Methotrexate—ankylosing spondylitis	0.0482	0.0668	CbGbCtD
Sevoflurane—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0377	0.0522	CbGbCtD
Sevoflurane—CYP3A4—Betamethasone—ankylosing spondylitis	0.0323	0.0448	CbGbCtD
Sevoflurane—CYP3A4—Prednisolone—ankylosing spondylitis	0.0319	0.0442	CbGbCtD
Sevoflurane—CYP3A4—Prednisone—ankylosing spondylitis	0.0301	0.0417	CbGbCtD
Sevoflurane—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0188	0.0261	CbGbCtD
Sevoflurane—ATP2C1—Ion channel transport—ANO6—ankylosing spondylitis	0.00238	0.0723	CbGpPWpGaD
Sevoflurane—GLRA1—Ion channel transport—ANO6—ankylosing spondylitis	0.00202	0.0615	CbGpPWpGaD
Sevoflurane—GABRQ—Orphan transporters—ANO6—ankylosing spondylitis	0.00148	0.0449	CbGpPWpGaD
Sevoflurane—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00133	0.00543	CcSEcCtD
Sevoflurane—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00133	0.00542	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.00131	0.00536	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.00131	0.00536	CcSEcCtD
Sevoflurane—Respiratory failure—Methotrexate—ankylosing spondylitis	0.0013	0.00529	CcSEcCtD
Sevoflurane—Pancreatitis—Prednisolone—ankylosing spondylitis	0.00129	0.00527	CcSEcCtD
Sevoflurane—GABRG3—Orphan transporters—ANO6—ankylosing spondylitis	0.00122	0.037	CbGpPWpGaD
Sevoflurane—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00121	0.00493	CcSEcCtD
Sevoflurane—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00121	0.00493	CcSEcCtD
Sevoflurane—GABRB1—Orphan transporters—ANO6—ankylosing spondylitis	0.0012	0.0364	CbGpPWpGaD
Sevoflurane—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.00119	0.00485	CcSEcCtD
Sevoflurane—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.00119	0.00484	CcSEcCtD
Sevoflurane—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.00118	0.00483	CcSEcCtD
Sevoflurane—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.00114	0.00466	CcSEcCtD
Sevoflurane—GABRA6—Orphan transporters—ANO6—ankylosing spondylitis	0.00113	0.0344	CbGpPWpGaD
Sevoflurane—GABRA4—Orphan transporters—ANO6—ankylosing spondylitis	0.00112	0.034	CbGpPWpGaD
Sevoflurane—Bradycardia—Prednisolone—ankylosing spondylitis	0.00107	0.00438	CcSEcCtD
Sevoflurane—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00106	0.00432	CcSEcCtD
Sevoflurane—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00105	0.0043	CcSEcCtD
Sevoflurane—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00105	0.00429	CcSEcCtD
Sevoflurane—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.00105	0.00428	CcSEcCtD
Sevoflurane—GABRQ—Ion channel transport—ANO6—ankylosing spondylitis	0.00104	0.0315	CbGpPWpGaD
Sevoflurane—Hepatic failure—Methotrexate—ankylosing spondylitis	0.00103	0.0042	CcSEcCtD
Sevoflurane—GABRB2—Orphan transporters—ANO6—ankylosing spondylitis	0.00102	0.0311	CbGpPWpGaD
Sevoflurane—Renal failure acute—Methotrexate—ankylosing spondylitis	0.001	0.00409	CcSEcCtD
Sevoflurane—GABRA5—Orphan transporters—ANO6—ankylosing spondylitis	0.000994	0.0302	CbGpPWpGaD
Sevoflurane—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000991	0.00404	CcSEcCtD
Sevoflurane—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000991	0.00404	CcSEcCtD
Sevoflurane—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000986	0.00403	CcSEcCtD
Sevoflurane—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.000984	0.00402	CcSEcCtD
Sevoflurane—GABRA3—Orphan transporters—ANO6—ankylosing spondylitis	0.000976	0.0297	CbGpPWpGaD
Sevoflurane—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000974	0.00397	CcSEcCtD
Sevoflurane—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000971	0.00397	CcSEcCtD
Sevoflurane—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000969	0.00395	CcSEcCtD
Sevoflurane—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000966	0.00394	CcSEcCtD
Sevoflurane—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.000961	0.00392	CcSEcCtD
Sevoflurane—GABRA2—Orphan transporters—ANO6—ankylosing spondylitis	0.000959	0.0292	CbGpPWpGaD
Sevoflurane—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.000955	0.0039	CcSEcCtD
Sevoflurane—GABRB3—Orphan transporters—ANO6—ankylosing spondylitis	0.000953	0.029	CbGpPWpGaD
Sevoflurane—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.000952	0.00388	CcSEcCtD
Sevoflurane—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.000952	0.00388	CcSEcCtD
Sevoflurane—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000941	0.00384	CcSEcCtD
Sevoflurane—Pancreatitis—Prednisone—ankylosing spondylitis	0.000938	0.00383	CcSEcCtD
Sevoflurane—GABRG2—Orphan transporters—ANO6—ankylosing spondylitis	0.000936	0.0284	CbGpPWpGaD
Sevoflurane—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000897	0.00366	CcSEcCtD
Sevoflurane—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000895	0.00365	CcSEcCtD
Sevoflurane—Bradycardia—Betamethasone—ankylosing spondylitis	0.000895	0.00365	CcSEcCtD
Sevoflurane—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000883	0.00361	CcSEcCtD
Sevoflurane—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000883	0.00361	CcSEcCtD
Sevoflurane—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000879	0.00359	CcSEcCtD
Sevoflurane—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000879	0.00359	CcSEcCtD
Sevoflurane—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000877	0.00358	CcSEcCtD
Sevoflurane—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000873	0.00356	CcSEcCtD
Sevoflurane—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000871	0.00356	CcSEcCtD
Sevoflurane—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000865	0.00353	CcSEcCtD
Sevoflurane—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000863	0.00352	CcSEcCtD
Sevoflurane—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000863	0.00352	CcSEcCtD
Sevoflurane—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000854	0.00348	CcSEcCtD
Sevoflurane—GABRG3—Ion channel transport—ANO6—ankylosing spondylitis	0.000853	0.0259	CbGpPWpGaD
Sevoflurane—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000847	0.00346	CcSEcCtD
Sevoflurane—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000841	0.00343	CcSEcCtD
Sevoflurane—GABRB1—Ion channel transport—ANO6—ankylosing spondylitis	0.00084	0.0255	CbGpPWpGaD
Sevoflurane—ATP2C1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000828	0.0252	CbGpPWpGaD
Sevoflurane—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000826	0.00337	CcSEcCtD
Sevoflurane—Syncope—Prednisolone—ankylosing spondylitis	0.000822	0.00336	CcSEcCtD
Sevoflurane—GABRA1—Orphan transporters—ANO6—ankylosing spondylitis	0.000818	0.0249	CbGpPWpGaD
Sevoflurane—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000806	0.00329	CcSEcCtD
Sevoflurane—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000797	0.00325	CcSEcCtD
Sevoflurane—Angiopathy—Betamethasone—ankylosing spondylitis	0.000797	0.00325	CcSEcCtD
Sevoflurane—GABRA6—Ion channel transport—ANO6—ankylosing spondylitis	0.000795	0.0242	CbGpPWpGaD
Sevoflurane—Convulsion—Prednisolone—ankylosing spondylitis	0.000794	0.00324	CcSEcCtD
Sevoflurane—Hypertension—Prednisolone—ankylosing spondylitis	0.000792	0.00323	CcSEcCtD
Sevoflurane—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000785	0.0032	CcSEcCtD
Sevoflurane—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000785	0.0032	CcSEcCtD
Sevoflurane—GABRA4—Ion channel transport—ANO6—ankylosing spondylitis	0.000785	0.0239	CbGpPWpGaD
Sevoflurane—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000784	0.0032	CcSEcCtD
Sevoflurane—Bradycardia—Prednisone—ankylosing spondylitis	0.000779	0.00318	CcSEcCtD
Sevoflurane—Haemoglobin—Prednisone—ankylosing spondylitis	0.000769	0.00314	CcSEcCtD
Sevoflurane—Haemorrhage—Prednisone—ankylosing spondylitis	0.000765	0.00312	CcSEcCtD
Sevoflurane—Syncope—Triamcinolone—ankylosing spondylitis	0.000756	0.00309	CcSEcCtD
Sevoflurane—Syncope—Methylprednisolone—ankylosing spondylitis	0.000755	0.00308	CcSEcCtD
Sevoflurane—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000748	0.00305	CcSEcCtD
Sevoflurane—Oedema—Prednisolone—ankylosing spondylitis	0.000748	0.00305	CcSEcCtD
Sevoflurane—Dysuria—Methotrexate—ankylosing spondylitis	0.000747	0.00305	CcSEcCtD
Sevoflurane—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000741	0.00303	CcSEcCtD
Sevoflurane—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000739	0.00302	CcSEcCtD
Sevoflurane—Shock—Prednisolone—ankylosing spondylitis	0.000736	0.00301	CcSEcCtD
Sevoflurane—Cough—Triamcinolone—ankylosing spondylitis	0.000736	0.003	CcSEcCtD
Sevoflurane—Convulsion—Triamcinolone—ankylosing spondylitis	0.000731	0.00298	CcSEcCtD
Sevoflurane—Tachycardia—Prednisolone—ankylosing spondylitis	0.00073	0.00298	CcSEcCtD
Sevoflurane—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000729	0.00298	CcSEcCtD
Sevoflurane—Hypertension—Triamcinolone—ankylosing spondylitis	0.000728	0.00297	CcSEcCtD
Sevoflurane—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000726	0.00296	CcSEcCtD
Sevoflurane—GABRB2—Ion channel transport—ANO6—ankylosing spondylitis	0.000718	0.0218	CbGpPWpGaD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000711	0.0029	CcSEcCtD
Sevoflurane—GLRA1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000704	0.0214	CbGpPWpGaD
Sevoflurane—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000702	0.00287	CcSEcCtD
Sevoflurane—Renal failure—Methotrexate—ankylosing spondylitis	0.0007	0.00286	CcSEcCtD
Sevoflurane—GABRA5—Ion channel transport—ANO6—ankylosing spondylitis	0.000697	0.0212	CbGpPWpGaD
Sevoflurane—Angiopathy—Prednisone—ankylosing spondylitis	0.000694	0.00283	CcSEcCtD
Sevoflurane—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000693	0.00283	CcSEcCtD
Sevoflurane—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000692	0.00283	CcSEcCtD
Sevoflurane—Immune system disorder—Prednisone—ankylosing spondylitis	0.000691	0.00282	CcSEcCtD
Sevoflurane—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000688	0.00281	CcSEcCtD
Sevoflurane—Oedema—Triamcinolone—ankylosing spondylitis	0.000688	0.00281	CcSEcCtD
Sevoflurane—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000687	0.0028	CcSEcCtD
Sevoflurane—Syncope—Betamethasone—ankylosing spondylitis	0.000686	0.0028	CcSEcCtD
Sevoflurane—Syncope—Dexamethasone—ankylosing spondylitis	0.000686	0.0028	CcSEcCtD
Sevoflurane—GABRA3—Ion channel transport—ANO6—ankylosing spondylitis	0.000685	0.0208	CbGpPWpGaD
Sevoflurane—Arrhythmia—Prednisone—ankylosing spondylitis	0.000684	0.00279	CcSEcCtD
Sevoflurane—Shock—Triamcinolone—ankylosing spondylitis	0.000677	0.00276	CcSEcCtD
Sevoflurane—Insomnia—Prednisolone—ankylosing spondylitis	0.000677	0.00276	CcSEcCtD
Sevoflurane—Shock—Methylprednisolone—ankylosing spondylitis	0.000676	0.00276	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000674	0.00275	CcSEcCtD
Sevoflurane—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000673	0.00275	CcSEcCtD
Sevoflurane—GABRA2—Ion channel transport—ANO6—ankylosing spondylitis	0.000673	0.0205	CbGpPWpGaD
Sevoflurane—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000672	0.00274	CcSEcCtD
Sevoflurane—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000672	0.00274	CcSEcCtD
Sevoflurane—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000672	0.00274	CcSEcCtD
Sevoflurane—Mental disorder—Prednisone—ankylosing spondylitis	0.000671	0.00274	CcSEcCtD
Sevoflurane—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00067	0.00274	CcSEcCtD
Sevoflurane—GABRB3—Ion channel transport—ANO6—ankylosing spondylitis	0.000669	0.0203	CbGpPWpGaD
Sevoflurane—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000667	0.00272	CcSEcCtD
Sevoflurane—Malnutrition—Prednisone—ankylosing spondylitis	0.000666	0.00272	CcSEcCtD
Sevoflurane—Convulsion—Betamethasone—ankylosing spondylitis	0.000663	0.00271	CcSEcCtD
Sevoflurane—Convulsion—Dexamethasone—ankylosing spondylitis	0.000663	0.00271	CcSEcCtD
Sevoflurane—Hypertension—Dexamethasone—ankylosing spondylitis	0.000661	0.0027	CcSEcCtD
Sevoflurane—Hypertension—Betamethasone—ankylosing spondylitis	0.000661	0.0027	CcSEcCtD
Sevoflurane—GABRG2—Ion channel transport—ANO6—ankylosing spondylitis	0.000657	0.02	CbGpPWpGaD
Sevoflurane—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000643	0.00262	CcSEcCtD
Sevoflurane—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000642	0.00262	CcSEcCtD
Sevoflurane—Pain—Prednisolone—ankylosing spondylitis	0.00064	0.00261	CcSEcCtD
Sevoflurane—Hepatitis—Methotrexate—ankylosing spondylitis	0.00064	0.00261	CcSEcCtD
Sevoflurane—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00064	0.00261	CcSEcCtD
Sevoflurane—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000635	0.00259	CcSEcCtD
Sevoflurane—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000632	0.00258	CcSEcCtD
Sevoflurane—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000627	0.00256	CcSEcCtD
Sevoflurane—Oedema—Dexamethasone—ankylosing spondylitis	0.000624	0.00255	CcSEcCtD
Sevoflurane—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000624	0.00255	CcSEcCtD
Sevoflurane—Oedema—Betamethasone—ankylosing spondylitis	0.000624	0.00255	CcSEcCtD
Sevoflurane—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000624	0.00255	CcSEcCtD
Sevoflurane—Insomnia—Triamcinolone—ankylosing spondylitis	0.000622	0.00254	CcSEcCtD
Sevoflurane—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000621	0.00253	CcSEcCtD
Sevoflurane—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000617	0.00252	CcSEcCtD
Sevoflurane—Shock—Dexamethasone—ankylosing spondylitis	0.000614	0.00251	CcSEcCtD
Sevoflurane—Shock—Betamethasone—ankylosing spondylitis	0.000614	0.00251	CcSEcCtD
Sevoflurane—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000614	0.0025	CcSEcCtD
Sevoflurane—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000612	0.0025	CcSEcCtD
Sevoflurane—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000612	0.0025	CcSEcCtD
Sevoflurane—Agitation—Prednisone—ankylosing spondylitis	0.000612	0.0025	CcSEcCtD
Sevoflurane—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000611	0.0025	CcSEcCtD
Sevoflurane—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000611	0.0025	CcSEcCtD
Sevoflurane—Tachycardia—Betamethasone—ankylosing spondylitis	0.000609	0.00249	CcSEcCtD
Sevoflurane—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000609	0.00249	CcSEcCtD
Sevoflurane—Syncope—Prednisone—ankylosing spondylitis	0.000598	0.00244	CcSEcCtD
Sevoflurane—Urticaria—Prednisolone—ankylosing spondylitis	0.000594	0.00243	CcSEcCtD
Sevoflurane—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000594	0.00242	CcSEcCtD
Sevoflurane—Pain—Triamcinolone—ankylosing spondylitis	0.000588	0.0024	CcSEcCtD
Sevoflurane—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000586	0.00239	CcSEcCtD
Sevoflurane—Hypotension—Betamethasone—ankylosing spondylitis	0.000583	0.00238	CcSEcCtD
Sevoflurane—Hypotension—Dexamethasone—ankylosing spondylitis	0.000583	0.00238	CcSEcCtD
Sevoflurane—Angiopathy—Methotrexate—ankylosing spondylitis	0.00058	0.00237	CcSEcCtD
Sevoflurane—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000578	0.00236	CcSEcCtD
Sevoflurane—Convulsion—Prednisone—ankylosing spondylitis	0.000577	0.00236	CcSEcCtD
Sevoflurane—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000577	0.00235	CcSEcCtD
Sevoflurane—Hypertension—Prednisone—ankylosing spondylitis	0.000575	0.00235	CcSEcCtD
Sevoflurane—Chills—Methotrexate—ankylosing spondylitis	0.000574	0.00234	CcSEcCtD
Sevoflurane—GABRA1—Ion channel transport—ANO6—ankylosing spondylitis	0.000574	0.0174	CbGpPWpGaD
Sevoflurane—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000567	0.00231	CcSEcCtD
Sevoflurane—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000566	0.00231	CcSEcCtD
Sevoflurane—Insomnia—Dexamethasone—ankylosing spondylitis	0.000565	0.00231	CcSEcCtD
Sevoflurane—Insomnia—Betamethasone—ankylosing spondylitis	0.000565	0.00231	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000563	0.0023	CcSEcCtD
Sevoflurane—Mental disorder—Methotrexate—ankylosing spondylitis	0.00056	0.00229	CcSEcCtD
Sevoflurane—Malnutrition—Methotrexate—ankylosing spondylitis	0.000557	0.00227	CcSEcCtD
Sevoflurane—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000551	0.00225	CcSEcCtD
Sevoflurane—Urticaria—Triamcinolone—ankylosing spondylitis	0.000547	0.00223	CcSEcCtD
Sevoflurane—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000545	0.00223	CcSEcCtD
Sevoflurane—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000545	0.00223	CcSEcCtD
Sevoflurane—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000544	0.00222	CcSEcCtD
Sevoflurane—Oedema—Prednisone—ankylosing spondylitis	0.000544	0.00222	CcSEcCtD
Sevoflurane—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000544	0.00222	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000539	0.0022	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000539	0.0022	CcSEcCtD
Sevoflurane—Shock—Prednisone—ankylosing spondylitis	0.000535	0.00218	CcSEcCtD
Sevoflurane—Pain—Betamethasone—ankylosing spondylitis	0.000534	0.00218	CcSEcCtD
Sevoflurane—Pain—Dexamethasone—ankylosing spondylitis	0.000534	0.00218	CcSEcCtD
Sevoflurane—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000533	0.00218	CcSEcCtD
Sevoflurane—Tachycardia—Prednisone—ankylosing spondylitis	0.000531	0.00217	CcSEcCtD
Sevoflurane—Skin disorder—Prednisone—ankylosing spondylitis	0.000528	0.00216	CcSEcCtD
Sevoflurane—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000515	0.0021	CcSEcCtD
Sevoflurane—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000515	0.0021	CcSEcCtD
Sevoflurane—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000507	0.00207	CcSEcCtD
Sevoflurane—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000506	0.00206	CcSEcCtD
Sevoflurane—Urticaria—Dexamethasone—ankylosing spondylitis	0.000496	0.00202	CcSEcCtD
Sevoflurane—Urticaria—Betamethasone—ankylosing spondylitis	0.000496	0.00202	CcSEcCtD
Sevoflurane—Dizziness—Prednisolone—ankylosing spondylitis	0.000495	0.00202	CcSEcCtD
Sevoflurane—Asthenia—Triamcinolone—ankylosing spondylitis	0.000494	0.00202	CcSEcCtD
Sevoflurane—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000494	0.00201	CcSEcCtD
Sevoflurane—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000494	0.00201	CcSEcCtD
Sevoflurane—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000493	0.00201	CcSEcCtD
Sevoflurane—Insomnia—Prednisone—ankylosing spondylitis	0.000492	0.00201	CcSEcCtD
Sevoflurane—Pruritus—Triamcinolone—ankylosing spondylitis	0.000487	0.00199	CcSEcCtD
Sevoflurane—Cough—Methotrexate—ankylosing spondylitis	0.000486	0.00198	CcSEcCtD
Sevoflurane—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000486	0.00198	CcSEcCtD
Sevoflurane—Convulsion—Methotrexate—ankylosing spondylitis	0.000482	0.00197	CcSEcCtD
Sevoflurane—Chest pain—Methotrexate—ankylosing spondylitis	0.000474	0.00194	CcSEcCtD
Sevoflurane—Rash—Prednisolone—ankylosing spondylitis	0.000472	0.00193	CcSEcCtD
Sevoflurane—Dermatitis—Prednisolone—ankylosing spondylitis	0.000471	0.00192	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000471	0.00192	CcSEcCtD
Sevoflurane—Headache—Prednisolone—ankylosing spondylitis	0.000469	0.00191	CcSEcCtD
Sevoflurane—Confusional state—Methotrexate—ankylosing spondylitis	0.000458	0.00187	CcSEcCtD
Sevoflurane—Dizziness—Triamcinolone—ankylosing spondylitis	0.000455	0.00186	CcSEcCtD
Sevoflurane—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000454	0.00186	CcSEcCtD
Sevoflurane—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000454	0.00185	CcSEcCtD
Sevoflurane—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000448	0.00183	CcSEcCtD
Sevoflurane—Asthenia—Betamethasone—ankylosing spondylitis	0.000448	0.00183	CcSEcCtD
Sevoflurane—Asthenia—Dexamethasone—ankylosing spondylitis	0.000448	0.00183	CcSEcCtD
Sevoflurane—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000446	0.00182	CcSEcCtD
Sevoflurane—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000445	0.00182	CcSEcCtD
Sevoflurane—Nausea—Prednisolone—ankylosing spondylitis	0.000445	0.00181	CcSEcCtD
Sevoflurane—Pruritus—Dexamethasone—ankylosing spondylitis	0.000442	0.0018	CcSEcCtD
Sevoflurane—Pruritus—Betamethasone—ankylosing spondylitis	0.000442	0.0018	CcSEcCtD
Sevoflurane—Skin disorder—Methotrexate—ankylosing spondylitis	0.000441	0.0018	CcSEcCtD
Sevoflurane—Vomiting—Triamcinolone—ankylosing spondylitis	0.000438	0.00179	CcSEcCtD
Sevoflurane—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000437	0.00178	CcSEcCtD
Sevoflurane—Rash—Triamcinolone—ankylosing spondylitis	0.000434	0.00177	CcSEcCtD
Sevoflurane—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000434	0.00177	CcSEcCtD
Sevoflurane—Rash—Methylprednisolone—ankylosing spondylitis	0.000433	0.00177	CcSEcCtD
Sevoflurane—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000433	0.00177	CcSEcCtD
Sevoflurane—Urticaria—Prednisone—ankylosing spondylitis	0.000432	0.00176	CcSEcCtD
Sevoflurane—Headache—Triamcinolone—ankylosing spondylitis	0.000431	0.00176	CcSEcCtD
Sevoflurane—Headache—Methylprednisolone—ankylosing spondylitis	0.00043	0.00176	CcSEcCtD
Sevoflurane—Body temperature increased—Prednisone—ankylosing spondylitis	0.00043	0.00175	CcSEcCtD
Sevoflurane—Hypotension—Methotrexate—ankylosing spondylitis	0.000425	0.00173	CcSEcCtD
Sevoflurane—Dizziness—Dexamethasone—ankylosing spondylitis	0.000413	0.00169	CcSEcCtD
Sevoflurane—Dizziness—Betamethasone—ankylosing spondylitis	0.000413	0.00169	CcSEcCtD
Sevoflurane—Insomnia—Methotrexate—ankylosing spondylitis	0.000411	0.00168	CcSEcCtD
Sevoflurane—Nausea—Triamcinolone—ankylosing spondylitis	0.000409	0.00167	CcSEcCtD
Sevoflurane—Nausea—Methylprednisolone—ankylosing spondylitis	0.000408	0.00166	CcSEcCtD
Sevoflurane—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000405	0.00165	CcSEcCtD
Sevoflurane—Somnolence—Methotrexate—ankylosing spondylitis	0.000404	0.00165	CcSEcCtD
Sevoflurane—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000401	0.00164	CcSEcCtD
Sevoflurane—Vomiting—Dexamethasone—ankylosing spondylitis	0.000397	0.00162	CcSEcCtD
Sevoflurane—Vomiting—Betamethasone—ankylosing spondylitis	0.000397	0.00162	CcSEcCtD
Sevoflurane—Rash—Betamethasone—ankylosing spondylitis	0.000394	0.00161	CcSEcCtD
Sevoflurane—Rash—Dexamethasone—ankylosing spondylitis	0.000394	0.00161	CcSEcCtD
Sevoflurane—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000393	0.00161	CcSEcCtD
Sevoflurane—Dermatitis—Betamethasone—ankylosing spondylitis	0.000393	0.00161	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000392	0.0016	CcSEcCtD
Sevoflurane—Headache—Betamethasone—ankylosing spondylitis	0.000391	0.0016	CcSEcCtD
Sevoflurane—Headache—Dexamethasone—ankylosing spondylitis	0.000391	0.0016	CcSEcCtD
Sevoflurane—Asthenia—Prednisone—ankylosing spondylitis	0.00039	0.00159	CcSEcCtD
Sevoflurane—Pain—Methotrexate—ankylosing spondylitis	0.000389	0.00159	CcSEcCtD
Sevoflurane—Pruritus—Prednisone—ankylosing spondylitis	0.000385	0.00157	CcSEcCtD
Sevoflurane—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000375	0.00153	CcSEcCtD
Sevoflurane—Nausea—Dexamethasone—ankylosing spondylitis	0.000371	0.00151	CcSEcCtD
Sevoflurane—Nausea—Betamethasone—ankylosing spondylitis	0.000371	0.00151	CcSEcCtD
Sevoflurane—Urticaria—Methotrexate—ankylosing spondylitis	0.000361	0.00147	CcSEcCtD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00036	0.011	CbGpPWpGaD
Sevoflurane—Dizziness—Prednisone—ankylosing spondylitis	0.00036	0.00147	CcSEcCtD
Sevoflurane—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000359	0.00147	CcSEcCtD
Sevoflurane—Vomiting—Prednisone—ankylosing spondylitis	0.000346	0.00141	CcSEcCtD
Sevoflurane—Rash—Prednisone—ankylosing spondylitis	0.000343	0.0014	CcSEcCtD
Sevoflurane—Dermatitis—Prednisone—ankylosing spondylitis	0.000343	0.0014	CcSEcCtD
Sevoflurane—Headache—Prednisone—ankylosing spondylitis	0.000341	0.00139	CcSEcCtD
Sevoflurane—GRIA1—Amyotrophic lateral sclerosis (ALS)—TNF—ankylosing spondylitis	0.00034	0.0103	CbGpPWpGaD
Sevoflurane—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000335	0.00137	CcSEcCtD
Sevoflurane—Asthenia—Methotrexate—ankylosing spondylitis	0.000326	0.00133	CcSEcCtD
Sevoflurane—Nausea—Prednisone—ankylosing spondylitis	0.000323	0.00132	CcSEcCtD
Sevoflurane—Pruritus—Methotrexate—ankylosing spondylitis	0.000322	0.00131	CcSEcCtD
Sevoflurane—Dizziness—Methotrexate—ankylosing spondylitis	0.000301	0.00123	CcSEcCtD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000297	0.00902	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000292	0.00889	CbGpPWpGaD
Sevoflurane—Vomiting—Methotrexate—ankylosing spondylitis	0.000289	0.00118	CcSEcCtD
Sevoflurane—Rash—Methotrexate—ankylosing spondylitis	0.000287	0.00117	CcSEcCtD
Sevoflurane—Dermatitis—Methotrexate—ankylosing spondylitis	0.000286	0.00117	CcSEcCtD
Sevoflurane—Headache—Methotrexate—ankylosing spondylitis	0.000285	0.00116	CcSEcCtD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000277	0.00841	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000273	0.0083	CbGpPWpGaD
Sevoflurane—Nausea—Methotrexate—ankylosing spondylitis	0.00027	0.0011	CcSEcCtD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00025	0.00759	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.000246	0.00746	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000243	0.00738	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000238	0.00724	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000234	0.00712	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000233	0.00707	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000229	0.00694	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0002	0.00607	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.00017	0.00515	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.000143	0.00434	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—B3GNT2—ankylosing spondylitis	0.000131	0.00399	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—B3GNT2—ankylosing spondylitis	0.000131	0.00399	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000122	0.00371	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.000121	0.00369	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—CRP—ankylosing spondylitis	0.000116	0.00353	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000114	0.00347	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—CRP—ankylosing spondylitis	9.23e-05	0.00281	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	6.46e-05	0.00196	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TNF—ankylosing spondylitis	5.26e-05	0.0016	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	4.62e-05	0.0014	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—TNF—ankylosing spondylitis	4.18e-05	0.00127	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—B3GNT2—ankylosing spondylitis	3.52e-05	0.00107	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—B3GNT2—ankylosing spondylitis	2.84e-05	0.000864	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—B3GNT2—ankylosing spondylitis	2.78e-05	0.000846	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—B3GNT2—ankylosing spondylitis	2.39e-05	0.000727	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	1.29e-05	0.000392	CbGpPWpGaD
